BNTC (Benitec Biopharma) Shiller PE Ratio: (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BNTC Benitec Biopharma Inc BNTC
31 GF Score
Price $12.21
View Full Analysis

What is Benitec Biopharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Benitec Biopharma  (NAS:BNTC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Benitec Biopharma Shiller PE Ratio Related Terms


Benitec Biopharma Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Shiller PE Ratio Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BNTC vs AVIR, ARCT, CMPX: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Benitec Biopharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benitec Biopharma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Shiller PE Ratio falls into.


BNTC
31GF Score
Benitec Biopharma Inc BNTC
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Benitec Biopharma's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Benitec Biopharma's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.24/330.2130*330.2130
=-0.240

Current CPI (Mar. 2026) = 330.2130.

Benitec Biopharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 -8.834 241.018 -12.103
201609 15.559 241.428 21.281
201612 -4.605 241.432 -6.298
201703 -0.368 243.801 -0.498
201706 -2.907 244.955 -3.919
201709 -56.018 246.819 -74.945
201712 -3.325 246.524 -4.454
201803 -3.027 249.554 -4.005
201806 -42.800 251.989 -56.086
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 -22.780 256.759 -29.297
201912 -34.000 256.974 -43.690
202003 -33.320 258.115 -42.627
202006 -46.580 257.797 -59.664
202009 -41.650 260.280 -52.841
202012 -12.920 260.474 -16.379
202103 -13.940 264.877 -17.379
202106 -8.328 271.696 -10.122
202109 -10.540 274.310 -12.688
202112 -10.030 278.802 -11.880
202203 -6.800 287.504 -7.810
202206 -10.510 296.311 -11.712
202209 -7.980 296.808 -8.878
202212 -3.340 296.797 -3.716
202303 -2.670 301.836 -2.921
202306 -2.650 305.109 -2.868
202309 -3.050 307.789 -3.272
202312 -2.640 306.746 -2.842
202403 -0.230 312.332 -0.243
202406 -0.110 314.175 -0.116
202409 -0.180 315.301 -0.189
202412 -0.260 315.605 -0.272
202503 -0.380 319.799 -0.392
202506 -0.210 322.561 -0.215
202509 -0.220 324.800 -0.224
202512 -0.260 324.054 -0.265
202603 -0.240 330.213 -0.240

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
31GF Score

Get the complete analysis for BNTC

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.21
Price